SIPS-Screening instrument for premenstrual symptoms. the German version of Premenstrual Symptoms Screening Tool to assess clinically relevant disturbances;SIPS-Screening-Instrument für prämenstruelle Symptome: Die deutsche Version des Premenstrual Symptoms Screening Tool zur Erfassung klinisch relevanter Beschwerden

Nervenarzt

Volumn 83, Issue 1, 2012, Pages 33-39

  Bentz, D ^a,b   Steiner, M ^c,d,e   Meinlschmidt, G ^a,b,f  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF TRIER   (Germany)

^c MCMASTER UNIVERSITY   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f Swiss Etiological Study of Adjustment and Mental Health (Sesam)   (Switzerland)

Author keywords

Clinical alarms; Functional somatic syndrome; Premenstrual dysphoric disorder; Premenstrual syndrome; Screening

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; GERMANY; HUMAN; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYMPTOMS SCREENING TOOL; PREMENSTRUAL SYNDROME; RATING SCALE; SCREENING; TEST RETEST RELIABILITY; VALIDITY;

ADULT; FEMALE; GERMANY; HUMANS; MASS SCREENING; PREMENSTRUAL SYNDROME; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84856375502     PISSN: 00282804     EISSN: 14330407     Source Type: Journal    
DOI: 10.1007/s00115-010-3210-6     Document Type: Article

References (27)

1. American Psychiatric Association (1994) Diagnosticand statistical manual of mental disorders. American Psychiatric Publishing Inc, Washington, DC
2. Angst J, Sellaro R, Merikangas KR et al (2001) The epidemiology of perimenstrual psychological symptoms. Acta Psychiatr Scand 104:110-116 (Pubitemid 32656086)
3. Bergant A, Schneider A, Tran T et al (2004) Diagnostikprä menstrueller Störungen. Dtsch Med Wochenschr 129:188-192
4. Budeiri DJ, Li Wan Po A, Dornan JC (1994) Clinical trials oftreatments of premenstrual syndrome: entry criteria and scales for measuring treatment outcomes. Br JObstet Gynaecol 101:689-695 (Pubitemid 24251523)
5. Dean BB, Borenstein JE, Knight K et al (2006) Evaluating the criteria used for identification of PMS. J Womens Health (Larchmt) 15:546-555 (Pubitemid 44082664)
6. Endicott J, Amsterdam J, Eriksson E et al (1999) Is premenstrual dysphoric disorder a distinct clinical entity? J Womens Health Gend Based Med 8:663-679 (Pubitemid 29414632)
7. Endicott J, Nee J, Harrison W (2006) Daily record of severityofproblems (DRSP): reliability and validity. Arch Womens Ment Health 9:41-49 (Pubitemid 43088573)
8. Freeman EW, Derubeis RJ, Rickels K (1996) Reliability and validity of a daily diary for premenstrual syndrome. Psychiatry Res 65:97-106 (Pubitemid 27052335)
9. Halbreich U, Borenstein J, Pearlstein T et al (2003) The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology (Suppl 28) 3:1-23 (Pubitemid 39658675)
10. Hylan TR, Sundell K, Judge R (1999) The impact of premenstrual symptomatology on functioning and treatmentseeking behavior: experiencefrom the United States, United Kingdom, and France.J Womens Health Gend Based Med 8:1043-1052 (Pubitemid 29537402)
11. Johnson SR (1987) The epidemiology and social impact of premenstrual symptoms. Clin Obstet Gynecol 30:367-376 (Pubitemid 17090229)
12. Kraemer GR, Kraemer RR (1998) Premenstrual syndrome: diagnosis and treatment experiences.J Womens Health 7:893-907
13. Mathias SD, Fifer SK, Patrick DL (1994) Rapid translation ofquality of life measures for international clinical trials: avoiding errors in the minimalist approach. Qual Life Res 3:403-412
14. Merikangas KR, Foeldenyi M, Angst J (1993) The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort Study. Eur Arch Psychiatry Clin Neurosci 243:23-32 (Pubitemid 23276042)
15. Mortola JF, Girton L, Beck L et al (1990) Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences. Obstet Gynecol 76:302-307 (Pubitemid 20227477)
16. Pearlstein TB, Halbreich U, Batzar ED et al (2000) Psychosocial functioning in women with premenstrual dysphoric disorder beforeand after treatment with sertraline or placebo. J Clin Psychiatry 61:101-109 (Pubitemid 30141642)
17. Reid RL (1985) Premenstrual syndrome. Curr Probl Obstet Gynecol Fertil 8:1-57
18. Robinson RL, Swindle RW (2000) Premenstrual symptom severity: impact on social functioning and treatmentseeking behaviors. J Womens Health Gend Based Med 9:757-768
19. Steiner M, Macdougall M, Brown E (2003) The premenstrual symptoms screening tool (PSST) for clinicians. Arch Women Ment Health 6:203-209 (Pubitemid 37046015)
20. Steiner M, Steinberg S, Stewart D et al (1995) Fluoxetine in thetreatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl JMed 332:1529-1534
21. Steiner M, Streiner DL, Steinberg S et al (1999) The measurement of premenstrual mood symptoms. J Affect Disord 53:269-273 (Pubitemid 29287665)
22. Sternfeld B, Swindle R, Chawla A et al (2002) Severityofpremenstrual symptoms in a health maintenance organization population. Obstet Gynecol 99:1014-1024 (Pubitemid 34621224)
23. Wittchen HU, Zaudig M, Fydrich T (1997) SKID-strukturiertes klinisches Interviewfür DSM-IVAchse I und II. Hogrefe, Göttingen
24. Wittchen HU, Becker E, Lieb R et al (2002) Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 32:119-132 (Pubitemid 33150508)
25. Woods NF, Most A, Dery GK (1982) Prevalene of perimenstrual symptoms. Am JPublic Health 72:1257-1264
26. Yonkers KA, Pearlstein T, Rosenheck RA (2003) Premenstrual disorders: bridging research and clinical reality. Arch Womens Ment Health 6:287-292 (Pubitemid 37484383)
27. Zung WWK (1996) Self-Rating Depression Scale. Selbstbeurteilungs-Skala (S). In: Scalarum CIP (Hrsg) Internationale Skalen für Psychiatrie. Beltz-Test, Göttingen, S101-103